Anzeige
Mehr »
Login
Dienstag, 05.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
300% Aktienanstieg war nur der Vorgeschmack – Warum diese Kupferstory noch besser wird!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
239 Leser
Artikel bewerten:
(1)

Solek Holding SE (Solek Group): SOLEK closes a USD379 million financing for its portfolio of PV projects in Chile

PRAGUE, May 31, 2023 /PRNewswire/ -- Solar energy group SOLEK has closed a USD379 million financing for its portfolio in Chile, consisting of solar photovoltaic utility-scale and PMGD plants located in the Central Region. The fast-growing company in the renewable and solar energy sector owns a portfolio of approximately 284MWdc in Chile and has more than 400MW of projects in development stage in Latin America.

SOLEK closes a USD379 million financing for its portfolio of PV projects in Chile

The comprehensive financing comprises the following facilities: A USD178 million senior private placement, A USD75 million mezzanine, a USD55 million PMGD bridge-loan facility, a USD37 million utility-scale bridge loan, a USD19 million LC Facility, and a USD15 million VAT line.

BNP Paribas and Natixis, New York Branch acted as placement agents, arrangers and lenders. BCI and Scotiabank Chile acted as agents and lenders on local facilities. White & Case and Guerrero Olivos acted respectively, as international and local legal counsels to the Company.

Entering the US private bond market with USD178 million issuance

Recently, the SOLEK company entered the major United States Private Placement market (USPP). The company has confirmed its attractiveness to investors and has gained flexible access to further financing. SOLEK is entering this new market with a 20-year bond issuance worth approximately USD178 million, or close to CZK 4 billion. The transaction had strong demand from investors, confirming the attractiveness of SOLEK's assets and the market's confidence in its long-term plans.

The USPP market is one of the largest and most sophisticated bond markets in the world. It is available to both, US and international companies. Active investors in the USPP market are represented by the largest international investment funds and insurance companies in the world.

"Thanks to the big opportunities that the renewable energy sector offers today, SOLEK has been experiencing a period of dynamic growth that implicates financing requirements. We had to meet stringent accreditation criteria to access financing on the USPP market. This flexible financing will allow us to focus on our PV projects and further development," said Zdenek Sobotka, founder, and CEO of the SOLEK Group.

Companies entering the USPP market typically issue long-term bonds. In line with the market practice, SOLEK's USPP bonds have an amortizing repayment schedule with a maturity of 20 years, which aligns the debt profile to the life of the underlying investment. The proceeds from the USPP bonds will be used primarily to finance the company's expansion plans and to refinance existing debt, setting an important milestone for SOLEK's continuous growth.

Since 2010, SOLEK has connected a total of 53 PV solar projects, 18 in Europe and 35 in Chile. The Group has currently more than 38 projects to be built in Chile in 2023 and 2024.

The total installed capacity targeted by the end of 2023 is 400 MW worldwide, most of them in Latin America. In Europe, PV solar projects with a total capacity of 1.4 GW are in the pipeline. The projects in Romania and Greece are at the most advanced stage of development. The first plants are planned to be connected in 2024.

SOLEK HOLDING SE

The SOLEK Group is a leading company engaged in the design, construction, and operation of solar power plants in Latin America and Europe. The company's clients include leading international investment companies, banks, funds, energy groups, and multinational companies.

The Group's main portfolio is located in Chile, where it manages more than three dozen photovoltaic power plants with a total capacity of over 200 MW. It also focuses on Europe, where it successfully develops existing projects while seeking new investment opportunities.

It is diversifying its activities to include innovative projects such as floating power plants, agro-photovoltaics, wind farms, battery storage including CO2 energy domes, green hydrogen production, and hybrid projects.

The company aims to complete 2GW of installed capacity by the end of 2027.

Photo: https://mma.prnewswire.com/media/2088767/Solek_Holding_SE_Solek_Group.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/solek-closes-a-usd379-million-financing-for-its-portfolio-of-pv-projects-in-chile-301837815.html

© 2023 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.